PCS499

· Processa Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PCS499, covering 2019-02-12 to 2022-10-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of PCS499 for the Treatment of Necrobiosis Lipoidica [Phase 2]